Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study ; volume:22 ; number:1 ; day:6 ; month:6 ; year:2023 ; pages:1-13 ; date:12.2023
International journal for equity in health ; 22, Heft 1 (6.6.2023), 1-13, 12.2023
- Creator
-
Antoniou, Tony
Pritlove, Cheryl
Shearer, Dana
Tadrous, Mina
Shah, Hemant
Gomes, Tara
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12939-023-01924-4
- URN
-
urn:nbn:de:101:1-2023091516132064876033
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Antoniou, Tony
- Pritlove, Cheryl
- Shearer, Dana
- Tadrous, Mina
- Shah, Hemant
- Gomes, Tara
- SpringerLink (Online service)
Other Objects (12)
Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Psychiatric treatment considerations with direct acting antivirals in hepatitis C
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Plant-derived antivirals against hepatitis c virus infection
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021
Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Psychiatric treatment considerations with direct acting antivirals in hepatitis C
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Plant-derived antivirals against hepatitis c virus infection
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era
Reported adverse events related to use of hepatitis C virus direct-acting antivirals with opioids: 2017–2021
Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Psychiatric treatment considerations with direct acting antivirals in hepatitis C
Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway
Hepatitis C clearance by direct-acting antivirals impacts glucose and lipid homeostasis
Managing HIV/hepatitis C co-infection in the era of direct acting antivirals
Impact of direct-acting antivirals on neuropsychiatric and neurocognitive dysfunction in chronic hepatitis C patients
Hepatitis C in the era of direct-acting antivirals: real-world costs of untreated chronic hepatitis C; a cross-sectional study
Plant-derived antivirals against hepatitis c virus infection
Effect of direct-acting antivirals on elastographic measures in patients with chronic hepatitis C virus infection
Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney disease
Continuum of hepatitis C care cascade in prison and following release in the direct-acting antivirals era